Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17752276 | 0.96 | KDM4E (0.34) | KDM4ENPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL17752277 | 0.92 | KDM4E (0.37) | KDM4ENPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL19176040 | 0.91 | — | — | |
| SCHEMBL17752274 | 0.89 | HDAC6 (0.33) | KDM4E | |
| SCHEMBL17752275 | 0.86 | — | — | |
| SCHEMBL17752269 | 0.86 | KDM4E (0.36) | KDM4ENPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL19175873 | 0.85 | KDM4E (0.31) | KDM4ENPC1RAB9AL3MBTL1 | |
| SCHEMBL17752265 | 0.83 | KDM4E (0.36) | KDM4ENPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL17752267 | 0.83 | KDM4E (0.34) | KDM4ENPC1ALDH1A1MAPTRAB9A | |
| SCHEMBL19175756 | 0.83 | NPC1 (0.40) | KDM4ENPC1ALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170213974-A1 | ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND | KYULUX, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170213974-A1 | ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND | CRY1, CRY2, CYBA | KDM4E 2784/4885NPC1 3146/4885ALDH1A1 269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.